Completed

3

1412

RoW

Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA

Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital

Acute Ischemic Stroke

06/23

06/23

Recruiting

3

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

Completed

2/3

900

RoW

ZX-7101A

Nanjing Zenshine Pharmaceuticals

Influenza, Human

05/23

10/23

Recruiting

2

460

RoW

TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Chronic Obstructive Pulmonary Disease (COPD)

01/24

05/24

Completed

2

18

RoW

bortezomib/dexamethasone

Institute of Hematology & Blood Diseases Hospital, China

Acquired Pure Red Cell Aplasia

07/24

09/24

Not yet recruiting

2

72

RoW

MY008211A tablets, MY008211A tablets matched placebo

Wuhan Createrna Science and Technology Co., Ltd

IgA Nephropathy (IgAN)

06/26

01/28

Recruiting

2

6642

RoW

Placebo, Chlorpheniramine

Institute of Hematology & Blood Diseases Hospital, China

Allergic Transfusion Reaction

12/25

06/26

Recruiting

1

290

RoW

oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology

Burning Mouth Syndrome, Oral Mucosa Disease

02/22

05/22

Recruiting

1

138

RoW

IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)

Changchun Intellicrown Pharmaceutical Co. LTD

Nonalcoholic Steatohepatitis (NASH)

07/24

12/24

Not yet recruiting

1

40

NA

BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON

Zhuhai Beihai Biotech Co., Ltd

Bioavailability

09/24

12/24

Completed

N/A

980

RoW

Rotational Atherectomy

Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.

Coronary Artery Disease

12/20

01/22

Recruiting

N/A

100

RoW

0.01% hypochlorous acid, 0.01%HOCI, Placebo

Eye & ENT Hospital of Fudan University, ShuGuang Hospital

Blepharitis

12/22

05/23

Recruiting

N/A

526

RoW

Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management

Peking University First Hospital

Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes

12/23

01/24

Recruiting

N/A

710

RoW

Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS

Ruijin Hospital, Dongfang Hospital Affiliated to Tongji University, Fudan University, Changhai Hospital, Shengjing Hospital, RenJi Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Provincial People's Hospital, Shandong Provincial Hospital, The General Hospital of Western Theater Command, Shanghai Jiao Tong University School of Medicine

Colorectal Cancer, Colon Cancer, Rectal Cancer

04/24

04/29

N/A

328

RoW

Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon

DK Medical Technology (Suzhou) Co., Ltd.

Arteriovenous Fistula Stenosis

07/27

07/27

Recruiting

N/A

10000

RoW

Installation or registration of smartphone application

Chinese Alliance Against Lung Cancer

Solitary Pulmonary Nodule

10/25

10/25

Not yet recruiting

N/A

550

RoW

lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Colorectal Neoplasms, Fluorescence, Lymph Node Excision

12/26

06/27

Recruiting

2

216

RoW

Yangxue Qingnao pills, Placebo

Dongzhimen Hospital, Beijing

Alzheimer Disease, Yangxue Qingnao Pills, Randomized

03/24

12/24

Recruiting

N/A

80

RoW

focused power ultrasound mediated inferior perirenal adipose tissue modification, sham-control group

The First Affiliated Hospital with Nanjing Medical University, The Affiliated Jiangning Hospital of Nanjing Medical University, Suzhou Municipal Hospital

Non-alcoholic Fatty Liver Disease

10/24

12/24

Recruiting

3

606

RoW

Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops

Oupushifang Pharmaceutical Technology Co., Ltd., Seefunge Pharmaceutical Technology Co., Ltd., AUTEK China Inc.

Myopia, Myopia Progression

12/26

12/27

Recruiting

2/3

226

RoW

ICP-248, Orelabrutinib

Beijing InnoCare Pharma Tech Co., Ltd.

Hematologic Malignancies

11/30

07/31

Completed

2

3

RoW

ICP-022

Beijing InnoCare Pharma Tech Co., Ltd.

Diffuse Large B Cell Lymphoma

11/21

12/21

Recruiting

2

55

RoW

Sintilimab, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone

The First Affiliated Hospital with Nanjing Medical University

EBV-Positive DLBCL, Nos

12/23

12/23

Active, not recruiting

2

62

RoW

Rocbrutinib, NWP-775, LP-168

Guangzhou Lupeng Pharmaceutical Company LTD.

Mantle Cell Lymphoma (MCL)

12/24

12/25

Recruiting

2

81

RoW

Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone

The First Affiliated Hospital with Nanjing Medical University

DLBCL, Untreated, MYC Gene Rearrangement

12/24

12/26

Recruiting

1/2

15

RoW

fhB7H3.CAR-Ts, B7H3 targeting chimeric antigen receptor T cells, Fludarabine, FLUDARA, Cyclophosphamide, Cytoxan

The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech Co. Ltd

Hepatocellular Carcinoma

02/24

02/27

Recruiting

1

37

RoW

TT-01488 Tablets

TransThera Sciences (Nanjing), Inc.

B-Cell Malignancies

10/26

10/28

Recruiting

N/A

124

RoW

Lenalidomide, Rituximab, Gemcitabine, oxaliplatin

The First Affiliated Hospital with Nanjing Medical University

Diffuse Large B Cell Lymphoma

12/22

12/24

Not yet recruiting

N/A

30

NA

Rituximab, Mitoxantrone hydrochloride liposome, Cyclophosphamide, Vincristine/Vindesine, Prednisone

The First Affiliated Hospital with Nanjing Medical University

Diffuse Large B-cell Lymphoma

08/23

08/24

Not yet recruiting

N/A

60

NA

Rituximab, Mitoxantrone hydrochloride liposome, Isophosphamide, Etoposide, X: Orelabrutinib, X: Chidamide, X: Penpulimab, X: Lenalidomide

The First Affiliated Hospital with Nanjing Medical University

Diffuse Large B-cell Lymphoma

01/24

01/25

Not yet recruiting

N/A

768

RoW

early pancreatic stent placement (EPSP), late pancreatic stent placement (EPSP)

The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital Bengbu Medical College, Anqing Municipal Hospital, First Affiliated Hospital of Wannan Medical College, Tongcheng People's Hospital of Anhui province, Fuyang people's hospital

Cholangiopancreatography, Endoscopic Rretrograde, Post-ERCP Pancreatitis

03/26

03/26

Not yet recruiting

N/A

72

RoW

Pegaspargase（P-GOD）, Pegaspargase（PEMD）

The First Affiliated Hospital with Nanjing Medical University

Extranodal NK/T Cell Lymphoma

07/24

07/25

Recruiting

N/A

30

RoW

CMOP+Chidamide

The First Affiliated Hospital with Nanjing Medical University

Newly Diagnosed Peripheral T-cell Lymphoma

01/25

01/25

Not yet recruiting

N/A

72

RoW

circulate free methylated EBV DNA

The First Affiliated Hospital with Nanjing Medical University, Zhenjiang First People's Hospital, Changzhou First People's Hospital, Changzhou Second People's Hospital, Wuxi People's Hospital, Second Affiliated Hospital of Soochow University, The First Affiliated Hospital of Nantong University, Huaian first people's hospital, Yancheng First People's Hospital

Extranodal Natural Killer/T-cell Lymphoma

06/25

06/28

Recruiting

N/A

268

US

Aortix System, Aortix Pump

Procyrion

07/25

12/25

Recruiting

N/A

200

RoW

Lidocaine Cataplasms

Qianfoshan Hospital

Adverse Reaction to Drug

10/22

12/22

Recruiting

3

510

Europe, Canada, Japan, US, RoW

LY3650150, Placebo, Standard therapy for INCS

Eli Lilly and Company

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

11/25

10/26

Recruiting

N/A

202

RoW

subtotal colectomy with cecal-rectal anastomosis, total colectomy with ileorectal anastomosis

Third Military Medical University

Slow Transit Constipation, Surgery

12/24

12/26

Recruiting

3

1680

RoW

Tranexamic acid, 0.9% sodium chloride

Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital

Hemorrhage, Postpartum, Placenta Previa

02/25

04/25

Not yet recruiting

N/A

81

NA

Linear EUS first, ME-NBI first

Nanfang Hospital of Southern Medical University

Early Rectal Cancer

06/22

12/22

Recruiting

N/A

240

RoW

Beijing Friendship Hospital

Degenerative Spondylolisthesis, Lumbar Spinal Stenosis

02/27

02/27

Recruiting

N/A

500

RoW

FFRCT-angio

First Affiliated Hospital of Harbin Medical University

Coronary Artery Disease

10/21

12/21

Recruiting

3

300

RoW

Fenofibrate

Xijing Hospital of Digestive Diseases

Primary Biliary Cholangitis (PBC)

12/35

12/35

Recruiting

3

320

Europe, Canada, US, RoW

DZD9008, Pemetrexed+carboplatin

Dizal Pharmaceuticals

Non-small Cell Lung Cancer

02/26

10/27

Completed

2

171

US, RoW

AZD4205

Dizal Pharmaceuticals

Relapsed or Refractory Peripheral T Cell Lymphoma

10/23

02/24

Recruiting

1

230

US, RoW

DZD8586

Dizal Pharmaceuticals

Lymphoma, Non-Hodgkin

04/27

10/27

Recruiting

N/A

10000

RoW

Shanghai Jiao Tong University School of Medicine, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, First Affiliated Hospital Bengbu Medical College, LanZhou University, Henan Cancer Hospital, The First Affiliated Hospital of Zhengzhou University, The Second Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, The First Hospital of Jilin University, Second Hospital of Jilin University, China-Japan Union Hospital, Jilin University, The First People's Hospital of Changzhou, Changzhou No.2 People's Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, The First People's Hospital of Taicang, Wuxi Second People's Hospital, Xuzhou Central Hospital, Second Affiliated Hospital of Suzhou University, Affiliated Hospital of Nantong University, The First People's Hospital of Nantong, The Affiliated Hospital of Xuzhou Medical University, Second Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Nanchang University, Jiangxi Provincial People's Hopital, Shengjing Hospital, Baotou Central Hospital, Qinghai People's Hospital, Changzhi Medical College, The First Affiliated Hospital of Shanxi Medical University, Shanxi Provincial Cancer Hospital, First Affiliated Hospital Xi'an Jiaotong University, Eastern Hepatobiliary Surgery Hospital, Shanghai Fengxian District Central Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Zhongshan Hospital, Shanghai Pudong Hospital, Central Hospital of Minhang District, Shanghai, Putuo District People's Hospital of Shanghai, Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Tianjin Medical University Cancer Hospital, First Affiliated Hospital of Xinjiang Medical University, The First Affiliated Hospital of Kunming Medical College, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Shaoxing Second Hospital, Shaoxing People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Cancer Hospital, Huizhou Municipal Central Hospital, Ningbo No. 1 Hospital, People's Hospital of Hunan Province, Hainan People's Hospital, Taizhou Municipal Hospital, Xinghua City People's Hospital, Tongliao City Hospital, Jiangxi Provincial Cancer Hospital, Shandong Provincial Hospital, Qilu Hospital of Shandong University, The Affiliated Hospital of Qingdao University, Xijing Hospital

Gallbladder Neoplasms

12/22

12/25

Recruiting

3

480

RoW

Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Hepatocellular Carcinoma

08/24

12/26

Recruiting

2

48

RoW

adebrelimab

Fujian Medical University Union Hospital, Sun Yat-sen University

Esophageal Squamous Cell Carcinoma, Immunotherapy, Biomarkers

12/25

12/28

Active, not recruiting

1

20

RoW

PD-1 plus stereotactic body radiotherapy

Shandong Cancer Hospital and Institute, BeiGene

Hepatocellular Carcinoma

12/24

12/24